Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
Moiseyenko FV, Moiseyenko VM, Aleksakhina SN, Chubenko VA, Volkov NM, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Ivantsov AO, Venina AR, Preobrazhenskaya EV, Mitiushkina NV, Iyevleva AG, Imyanitov EN. Moiseyenko FV, et al. Among authors: venina ar. Oncol Res Treat. 2016;39(10):605-614. doi: 10.1159/000449024. Epub 2016 Sep 15. Oncol Res Treat. 2016. PMID: 27710972 Clinical Trial.
BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
Frank GA, Aleksakhina SN, Zavalishina LE, Kekeyeva TV, Venina AR, Ivantsov AO, Mitiushkina NV, Moiseyenko AV, Pfeifer W, Strelkova TN, Imyanitov EN. Frank GA, et al. Among authors: venina ar. Melanoma Res. 2016 Oct;26(5):442-7. doi: 10.1097/CMR.0000000000000278. Melanoma Res. 2016. PMID: 27433783 No abstract available.
Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
Yanus GA, Akhapkina TA, Ivantsov AO, Preobrazhenskaya EV, Aleksakhina SN, Bizin IV, Sokolenko AP, Mitiushkina NV, Kuligina ES, Suspitsin EN, Venina AR, Holmatov MM, Zaitseva OA, Yatsuk OS, Pashkov DV, Belyaev AM, Togo AV, Imyanitov EN, Iyevleva AG. Yanus GA, et al. Among authors: venina ar. Clin Genet. 2018 May;93(5):1015-1021. doi: 10.1111/cge.13228. Epub 2018 Mar 9. Clin Genet. 2018. PMID: 29406563
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Moiseyenko VM, Moiseyenko FV, Yanus GA, Kuligina ES, Sokolenko AP, Bizin IV, Kudriavtsev AA, Aleksakhina SN, Volkov NM, Chubenko VA, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Pashkov DV, Ivantsov AO, Venina AR, Sokolova TN, Preobrazhenskaya EV, Mitiushkina NV, Togo AV, Iyevleva AG, Imyanitov EN. Moiseyenko VM, et al. Among authors: venina ar. Clin Drug Investig. 2018 Jun;38(6):553-562. doi: 10.1007/s40261-018-0629-1. Clin Drug Investig. 2018. PMID: 29470838
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I.
Orlova KV, Yanus GA, Aleksakhina SN, Venina AR, Iyevleva AG, Demidov LV, Imyanitov EN. Orlova KV, et al. Among authors: venina ar. Case Rep Oncol. 2019 Jan 23;12(1):109-112. doi: 10.1159/000495782. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 31043947 Free PMC article.
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN. Kuligina ES, et al. Among authors: venina ar. Breast Cancer Res Treat. 2020 Feb;179(3):731-742. doi: 10.1007/s10549-019-05492-6. Epub 2019 Nov 21. Breast Cancer Res Treat. 2020. PMID: 31754952
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Daks A, Mamontova V, Fedorova O, Petukhov A, Shuvalov O, Parfenyev S, Netsvetay S, Venina A, Kizenko A, Imyanitov E, Barlev N. Daks A, et al. Biochem Biophys Res Commun. 2021 Oct 1;572:41-48. doi: 10.1016/j.bbrc.2021.07.086. Epub 2021 Jul 31. Biochem Biophys Res Commun. 2021. PMID: 34343833
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
Iyevleva AG, Aleksakhina SN, Sokolenko AP, Baskina SV, Venina AR, Anisimova EI, Bizin IV, Ivantsov AO, Belysheva YV, Chernyakova AP, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: venina ar. Breast Cancer Res Treat. 2022 Apr;192(2):283-291. doi: 10.1007/s10549-022-06517-3. Epub 2022 Jan 12. Breast Cancer Res Treat. 2022. PMID: 35020107
14 results